The technology, which is still in the research and development phase, allows for “for more precise 3D visualization of different tissues and contrast agents by capturing X-rays at multiple energy levels simultaneously,” according to a Feb. 25 news release from the university.
“This could improve cancer detection,” study author Mini Das, PhD, a professor at the University of Houston, said in the release. “If you inject two different contrast agents — one targeting a tumor and another targeting inflammation — you could see where each one accumulates.”
Read the full study here.
